PATHWAY CAPITAL MANAGEMENT, LP

IRVINE, CA · Quarter end: Sep 30, 2026 · Filed with SEC: Oct 29, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$19.5M2026 Q3
Positions4
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.100.0%

PATHWAY CAPITAL MANAGEMENT, LP reported 4 positions worth $19.5M as of September 30, 2026 (13F filed October 29, 2026). Largest holding: LYNX (56.0%). Biggest move: exit RBRK ($12.8M).

4 positions shown
#SymbolCompanyValue ↓% Port.Shares1YYTDSince reported
▸ 1 LYNXLyntris$10.9M56.02%885,888——+9.4%
▸ 2 HNGEHinge Health$7.7M39.62%79,492——+24.7%
▸ 3 NTSKNetskope$579.2K2.97%33,213——+25.3%
▸ 4 UUnity Software$271.6K1.39%6,636——+26.8%

Read the 2026-Q2 quarterly report · 13F Filing Calendar

🔔 Tell me when this fund files a new 13F

No account needed: in your inbox the morning it is published.

Frequently Asked Questions

What stocks does PATHWAY CAPITAL MANAGEMENT, LP hold as of Q3 2026?

PATHWAY CAPITAL MANAGEMENT, LP reported 4 positions worth $19.5M in its Q3 2026 13F filing. Largest positions: LYNX (56.0%), HNGE (39.6%), NTSK (3.0%) and U (1.4%).

What did PATHWAY CAPITAL MANAGEMENT, LP buy in Q3 2026?

New positions: LYNX, HNGE, NTSK and U.

What did PATHWAY CAPITAL MANAGEMENT, LP sell in Q3 2026?

Sold out entirely: RBRK, HOOD, TTAN and BLND.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.